|
CAESAREA, Israel, April 29, 2026 /PRNewswire/ -- Alma, a Sisram Medical company and a global leader in medical aesthetic solutions, unveiled its longevity strategy at its global Alma Academy, outlining its shift toward a continuous care model and a new long-term growth approach.
In remarks to 430 physicians from 45 countries, Alma CEO Eyal Ben David outlined the company's transition toward a platform enabling continuous, outcomes-driven care.
"Longevity is redefining aesthetics as a discipline of performance over time," said Mr. Ben David. "The focus is on enhancing how skin functions, adapts, and maintains quality, through controlled biological responses that drive regeneration, resilience, and structural improvement. This approach enables practitioners to deliver measurable, sustained outcomes and build long-term value through consistent skin performance. At the core of this is the operating system of modern aesthetics, an integrated, end-to-end system designed to orchestrate the entire patient journey and redefine how care is delivered over time."
The company highlighted that this approach reflects a broader shift in consumer expectations, with patients increasingly prioritizing prevention, long-term results, and personalized experiences. Alma's longevity approach focuses on enhancing skin function and quality over time, starting earlier, extending engagement, and delivering sustained, measurable outcomes through an integrated ecosystem of technologies designed to activate the skin's natural regenerative and adaptive responses.
This year's global summit brought together 19 world-class experts from across the industry to share insights, research, and real-world case studies. Notable speakers included Dr. Spero Theodorou, Prof. Ofir Artzi, Dr. Pablo Naranjo, Dr. Tino Solomon, and Dr. Jaerim Kim, alongside other leading experts from around the world.
Sessions covered key clinical indications shaping the future of medical aesthetics, including skin rejuvenation, vascular indications, acne and acne scars, pigmentation, skin laxity, scars, and the treatment of challenging skin conditions, reflecting the industry's growing emphasis on comprehensive, long-term patient care.
Alma Academy continues to serve as a premier global platform for education, innovation, and collaboration, bringing together leading practitioners to exchange knowledge, advance clinical excellence, and experience the latest technologies through live demonstrations.
About Alma
Alma is a global leader in medical aesthetic solutions, with over 25 years of innovation. The company empowers practitioners to deliver safe, effective, and transformative treatments through state-of-the-art, clinically proven solutions spanning energy-based lasers, skin analysis, injectables, and advanced skincare. Alma's multiple award-winning products have set new benchmarks in the medical aesthetics industry, combining clinical excellence with groundbreaking innovation.
Media Inquiries
prglobal@almalasers.com
CAESAREA, Israel, April 29, 2026 /PRNewswire/ -- Alma, a Sisram Medical company and a global leader in medical aesthetic solutions, unveiled its longevity strategy at its global Alma Academy, outlining its shift toward a continuous care model and a new long-term growth approach.
In remarks to 430 physicians from 45 countries, Alma CEO Eyal Ben David outlined the company's transition toward a platform enabling continuous, outcomes-driven care.
"Longevity is redefining aesthetics as a discipline of performance over time," said Mr. Ben David. "The focus is on enhancing how skin functions, adapts, and maintains quality, through controlled biological responses that drive regeneration, resilience, and structural improvement. This approach enables practitioners to deliver measurable, sustained outcomes and build long-term value through consistent skin performance. At the core of this is the operating system of modern aesthetics, an integrated, end-to-end system designed to orchestrate the entire patient journey and redefine how care is delivered over time."
The company highlighted that this approach reflects a broader shift in consumer expectations, with patients increasingly prioritizing prevention, long-term results, and personalized experiences. Alma's longevity approach focuses on enhancing skin function and quality over time, starting earlier, extending engagement, and delivering sustained, measurable outcomes through an integrated ecosystem of technologies designed to activate the skin's natural regenerative and adaptive responses.
This year's global summit brought together 19 world-class experts from across the industry to share insights, research, and real-world case studies. Notable speakers included Dr. Spero Theodorou, Prof. Ofir Artzi, Dr. Pablo Naranjo, Dr. Tino Solomon, and Dr. Jaerim Kim, alongside other leading experts from around the world.
Sessions covered key clinical indications shaping the future of medical aesthetics, including skin rejuvenation, vascular indications, acne and acne scars, pigmentation, skin laxity, scars, and the treatment of challenging skin conditions, reflecting the industry's growing emphasis on comprehensive, long-term patient care.
Alma Academy continues to serve as a premier global platform for education, innovation, and collaboration, bringing together leading practitioners to exchange knowledge, advance clinical excellence, and experience the latest technologies through live demonstrations.
About Alma
Alma is a global leader in medical aesthetic solutions, with over 25 years of innovation. The company empowers practitioners to deliver safe, effective, and transformative treatments through state-of-the-art, clinically proven solutions spanning energy-based lasers, skin analysis, injectables, and advanced skincare. Alma's multiple award-winning products have set new benchmarks in the medical aesthetics industry, combining clinical excellence with groundbreaking innovation.
Media Inquiries
prglobal@almalasers.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Alma Unveils Longevity Approach at Alma Academy, Advancing Long-Term Skin Performance
Alma Unveils Longevity Approach at Alma Academy, Advancing Long-Term Skin Performance
Littlejohn's Tree Frogs breed within 72 hours of arrival at WILD LIFE Sydney Zoo
Download high-res images and vision here.
SYDNEY, April 29, 2026 /PRNewswire/ -- WILD LIFE Sydney Zoo has announced a groundbreaking achievement in conservation with the success of its first-ever on-site breed for release program. Within just 72 hours of arriving at a new custom-built facility, endangered frog species Littlejohn's Tree Frogs (Litoria littlejohni) have successfully produced three clutches of eggs, a milestone never before achieved in a zoo setting.
The achievement is the result of over a year of preparation in partnership with the University of Newcastle's Centre of Conservation Science and Amphibian ICU. The Littlejohn's Tree frog is an elusive native species facing imminent extinction, with threats such climate change, extreme habitat loss and degradation, and chytrid disease - an amphibian fungus which affects many Australian frog species. The impact of these threats has led to small and isolated populations, with reduced genetic diversity and therefore decreased reproduction and survival rates of tadpoles and metamorphs.
The species is now found in only three remaining locations in the New South Wales Sydney Basin from the Watagan State Forest to the Woronora Plateau, and only with five fragmented populations.
The zoo received a cohort of 58 frogs from the University of Newcastle's Centre for Conservation Research and Amphibian ICU, including 22 wild founder individuals and 36 sub-adults hatched at the University last winter.
Ashley Wombey, Curatorial Manager Conservation, Population and Science said: "It has been over 12 months of preparation, which has included building a purpose-built breeding facility affectionately naming our "Frogservation Lab", installing life support systems with continual testing and monitoring to provide the ideal parameters that reflect their wild habitat. The speed at which the frogs have displayed breeding behaviours tells us they have settled very quickly and that we have provided the perfect conditions for them to flourish. Not only is their arrival exciting, it is an important step in safeguarding the future of the species. We are very excited to partner with the University of Newcastle, as the future of conservation is through collaboration."
Dr Alex Callen from the University of Newcastle's Amphibian ICU within the Centre for Conservation Science said: "The achievement is very exciting as it is only the second time that this species has been bred in human care. This Littlejohn's tree frog breeding program focuses on improving the genetic diversity of the species as it now occurs from only three isolated regions in the world."
By establishing this breeding colony in the heart of Sydney, the zoo is ensuring that even if wild populations continue to decline, a genetically diverse "insurance population" is ready to be returned to the wild.
While a number of tadpoles have already hatched, they are in a sensitive stage of development. The zoo team is monitoring the remaining eggs closely, with more hatchlings anticipated within the next couple of weeks.
Visitors can learn more about this exciting project and get a glimpse of the "Frogservation Lab" now at WILD LIFE Sydney Zoo.
About Merlin Entertainments Merlin Entertainments is a world leader in branded entertainment destinations across the UK, US, Western Europe, China, and Asia Pacific. Dedicated to creating experiences that inspire joy and connection, Merlin welcomes more than 62 million guests annually to its growing estate, with over 140 sites across 23 countries.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
World first for endangered frogs facing extinction
World first for endangered frogs facing extinction
World first for endangered frogs facing extinction
